Image

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

Clinical trial for AML with BP1001, Venetoclax, and Decitabine combination.

Recruiting
18 years and older
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study looks at a new treatment for a type of blood cancer called Acute Myeloid Leukemia (AML). It uses three drugs: BP1001, venetoclax, and decitabine. BP1001 is a special treatment that stops the Grb2 protein, which helps cancer cells grow. Venetoclax and decitabine are medicines used for AML. The study compares how well these drugs work together against AML compared to older treatments.

AML patients who haven't been treated or who didn't get better with other treatments can join. The study will have three groups: one with all three drugs, one with BP1001 and decitabine, and one for those who can't use venetoclax.

  • Duration: The study will continue until enough participants have been treated in each group.
  • Eligibility: Participants must be 18 or older and meet specific health criteria.
  • Safety: The study will monitor participants closely for any side effects.

If you join, you'll help researchers find better ways to treat AML. Always talk to your doctor to see if joining is right for you.

Print
Study details
    Acute Myeloid Leukemia (AML)

NCT02781883

Bio-Path Holdings, Inc.

15 March 2025

Contact a study center
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.